Anti-proliferative effect of radiolabell
✍
Gerrit D. Slooter; Wouter A.P. Breeman; Richard L. Marquet; Eric P. Krenning; Ca
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
French
⚖ 186 KB
👁 2 views
Most neuroendocrine tumours and several other tumours, such as breast carcinoma and malignant lymphoma, express somatostatin receptors (SS-Rs). Lesions expressing these receptors can be visualised by receptor scintigraphy using a low radioactive dose of the radiolabelled SS analogue [ 111 In-DTPA 0